|
Showing 1 - 2 of
2 matches in All Departments
As part of the overall disability determination process, the Social
Security Administration uses a step-by-step approach to understand
how severe an individual's condition is and whether it meets
program criteria for disability. The use of various types of
biomarkers has been suggested as a way to strengthen the amount and
quality of objective evidence available to the review process. At
the request of the Social Security Administration, the National
Academies of Sciences, Engineering, and Medicine's Board on Health
Care Services organized a virtual workshop on July 21, 2020, titled
The State of the Science of the Use of Biomarkers to Establish the
Presence and Severity of Impairments. Workshop discussions focused
on the current and potential uses for biomarkers; explored legal
and ethical implications associated with biomarker use in clinical
decision making; and considered the possible uses of nongenetic
biomarkers as tools for the diagnosis or prognosis of the severity
of specific physical and mental impairments. This publication
summarizes the presentations and discussion of the workshop. Table
of Contents Front Matter 1 Introduction 2 Understanding Biomarker
Use and Its Potential for Determining Health and Function 3 State
of the Science for Specific Impairments 4 Legal and Ethical
Implications 5 Final Thoughts References Appendix A: Statement of
Task Appendix B: Workshop Agenda Appendix C: Biographical Sketches
of Workshop Speakers and Planning Committee Members
Delivering high-quality cancer care to all patients presents
numerous challenges, including difficulties with care coordination
and access. Patient navigation is a community-based service
delivery intervention designed to promote access to timely
diagnosis and treatment of cancer and other chronic diseases by
eliminating barriers to care, and has often been proposed and
implemented to address these challenges. However, unresolved
questions include where patient navigation programs should be
deployed, and which patients should be prioritized to receive
navigation services when resources are limited. To address these
issues and facilitate discussion on how to improve navigation
services for patients with cancer, the National Cancer Policy Forum
of the National Academies of Sciences, Engineering, and Medicine
held a workshop on November 13 and 14, 2017. At this workshop, a
broad range of experts and stakeholders, including clinicians,
navigators, researchers, and patients, explored which patients need
navigation and who should serve as navigators, and the benefits of
navigation and current gaps in the evidence base. Table of Contents
Front Matter Proceedings of a Workshop Appendix A: Statement of
Task Appendix B: Workshop Agenda
|
|